The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Molindone for schizophrenia and severe mental illness
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2007
|
| DOI | 10.1002/14651858.cd002083.pub2 |
| Pubmed ID | |
| Authors |
Anne‐Marie Bagnall, Mark Fenton, Jos Kleijnen, Ruth Lewis |
| Abstract |
Antipsychotic therapy is the mainstay of treatment for people with schizophrenia. In recent years new or atypical antipsychotics have been introduced. These are less likely to produce movement disorders and raise serum prolactin. Researchers have suggested that molindone should be classified as an atypical antipsychotic. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Australia | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 148 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 14% |
| Student > Bachelor | 18 | 12% |
| Researcher | 17 | 11% |
| Student > Ph. D. Student | 17 | 11% |
| Student > Doctoral Student | 9 | 6% |
| Other | 26 | 17% |
| Unknown | 42 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 30% |
| Psychology | 19 | 13% |
| Nursing and Health Professions | 15 | 10% |
| Social Sciences | 6 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Other | 15 | 10% |
| Unknown | 46 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2023.
All research outputs
#3,135,241
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#5,792
of 11,842 outputs
Outputs of similar age
#11,971
of 173,990 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 70 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,990 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.